Immunosuppressive Mechanisms of Regulatory B Cells
- PMID: 33995344
- PMCID: PMC8118522
- DOI: 10.3389/fimmu.2021.611795
Immunosuppressive Mechanisms of Regulatory B Cells
Abstract
Regulatory B cells (Bregs) is a term that encompasses all B cells that act to suppress immune responses. Bregs contribute to the maintenance of tolerance, limiting ongoing immune responses and reestablishing immune homeostasis. The important role of Bregs in restraining the pathology associated with exacerbated inflammatory responses in autoimmunity and graft rejection has been consistently demonstrated, while more recent studies have suggested a role for this population in other immune-related conditions, such as infections, allergy, cancer, and chronic metabolic diseases. Initial studies identified IL-10 as the hallmark of Breg function; nevertheless, the past decade has seen the discovery of other molecules utilized by human and murine B cells to regulate immune responses. This new arsenal includes other anti-inflammatory cytokines such IL-35 and TGF-β, as well as cell surface proteins like CD1d and PD-L1. In this review, we examine the main suppressive mechanisms employed by these novel Breg populations. We also discuss recent evidence that helps to unravel previously unknown aspects of the phenotype, development, activation, and function of IL-10-producing Bregs, incorporating an overview on those questions that remain obscure.
Keywords: CD1d; IL-10; IL-35; PD-L1; TGF-β; TIM-1; granzyme B; regulatory B cells.
Copyright © 2021 Catalán, Mansilla, Ferrier, Soto, Oleinika, Aguillón and Aravena.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Interleukin 35 Regulatory B Cells.J Mol Biol. 2021 Jan 8;433(1):166607. doi: 10.1016/j.jmb.2020.07.019. Epub 2020 Aug 2. J Mol Biol. 2021. PMID: 32755620 Free PMC article. Review.
-
Advances of Regulatory B Cells in Autoimmune Diseases.Front Immunol. 2021 Apr 15;12:592914. doi: 10.3389/fimmu.2021.592914. eCollection 2021. Front Immunol. 2021. PMID: 33936028 Free PMC article. Review.
-
Regulatory B Cells-Immunopathological and Prognostic Potential in Humans.Cells. 2024 Feb 18;13(4):357. doi: 10.3390/cells13040357. Cells. 2024. PMID: 38391970 Free PMC article. Review.
-
Regulatory B cells in infectious disease (Review).Mol Med Rep. 2017 Jul;16(1):3-10. doi: 10.3892/mmr.2017.6605. Epub 2017 May 18. Mol Med Rep. 2017. PMID: 28534949 Free PMC article. Review.
-
New Insights into IL-10 Dependent and IL-10 Independent Mechanisms of Regulatory B Cell Immune Suppression.J Clin Immunol. 2016 May;36 Suppl 1:25-33. doi: 10.1007/s10875-016-0263-8. Epub 2016 Mar 23. J Clin Immunol. 2016. PMID: 27008462 Review.
Cited by
-
Advances in the study of B cells in renal ischemia-reperfusion injury.Front Immunol. 2023 Nov 1;14:1216094. doi: 10.3389/fimmu.2023.1216094. eCollection 2023. Front Immunol. 2023. PMID: 38022595 Free PMC article. Review.
-
The emerging roles and therapeutic potential of B cells in sepsis.Front Pharmacol. 2022 Nov 8;13:1034667. doi: 10.3389/fphar.2022.1034667. eCollection 2022. Front Pharmacol. 2022. PMID: 36425582 Free PMC article. Review.
-
Enhancement the antioxidative and immunomodulatory functions of mesenchymal stem cells by tetrandrine.Heliyon. 2024 Aug 2;10(16):e35667. doi: 10.1016/j.heliyon.2024.e35667. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39220890 Free PMC article.
-
CD39/CD73/A2AR pathway and cancer immunotherapy.Mol Cancer. 2023 Mar 2;22(1):44. doi: 10.1186/s12943-023-01733-x. Mol Cancer. 2023. PMID: 36859386 Free PMC article. Review.
-
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.Cancers (Basel). 2023 Jan 6;15(2):376. doi: 10.3390/cancers15020376. Cancers (Basel). 2023. PMID: 36672326 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous